Eli Lilly and Co


Eli Lilly And Incyte’s Baricitinib Fails To Meet Endpoint In Phase 3 COVID-19 Trial

Eli Lilly and Co. And Incyte reported data from their phase 3 study of baricitinib in hospitalized COVID-19 patients.

Eli Lilly Ends Covid-19 Trial In Hospitalized Patients On Disappointing Data

Eli Lilly & Co. announced on Monday that it will stop a US-based clinical trial for its COVID-19 antibody treatment after data found …

Eli Lilly, Innovent’s TYVYT Expanded Use Application Accepted In China

Eli Lilly (LLY) and Innovent Biologics have announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental New Drug …

Eli Lilly, Innovent Deliver Encouraging Lung Cancer Data For Sintilimab

Eli Lilly (LLY) and Innovent Biologics have announced encouraging interim analysis data from ORIENT-11 at the virtual IASLC World Conference on Lung Cancer …

Chi-Med, Eli Lilly Link Up For Commercializing Elunate In China

Hutchison China MediTech (HCM) and Eli Lilly (LLY) have announced an amendment to the 2013 License and Collaboration Agreement on Fruquintinib. The 2020 …

Eli Lilly Leaps 13% On Positive Results For Its Verzenio Breast Cancer Therapy

Shares in Eli Lilly & Co (LLY) jumped 13% after the drugmaker reported that the results of a late stage study of its …

Junshi Biosciences Kicks Off China’s First Covid-19 Antibody Trial

Junshi Biosciences has announced that the first healthy volunteer has been dosed in a Phase I clinical study of JS016 in China. JS016 is …

Eli Lilly’s Taltz Injection Gets FDA Nod For Inflammatory Spine Arthritis Treatment

Drugmaker Eli Lilly & Co (LLY) said that the U.S.

Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2

Junshi Biosciences Co Ltd said on Tuesday that it is gearing up to initiate clinical trials to test its experimental COVID-19 antibodies together …

Eli Lilly Wins FDA Approval For Retevmo Lung, Thyroid Cancer Treatment

Drugmaker Eli Lilly & Co (LLY) said the U.S.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts